跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ALPRAZOLAM NEURAXPHARM 0,25 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ALPRAZOLAM NEURAXPHARM 0,25 MG COMPRIMIDOS EFG
Approved
STANDARD
ALPRAZOLAM NEURAXPHARM 0,25 MG COMPRIMIDOS EFG
Neuraxpharm Spain S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 29, 2021
Approval ID
c32120464d484c0c
Company
Neuraxpharm Spain S.L.
Type
Standard
Approval Details
Approval Id
c32120464d484c0c
Drug Cima Aemps Name
ALPRAZOLAM NEURAXPHARM 0,25 MG COMPRIMIDOS EFG
Register Number
86320
Holder Company Name
Neuraxpharm Spain S.L.
Marketing Company Name
Neuraxpharm Spain S.L.
Authorization Date
2021-11-29
Dosage Form
COMPRIMIDO
Dose
0,25 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Psicótropos
Commercialized
No
Company Name
Neuraxpharm Spain S.L.
Active Ingredients
ALPRAZOLAM
0,25 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 29, 2021
Approval ID
c32120464d484c0c
Type
Standard
Back to CIMA-AEMPS Approvals
